Literature DB >> 35464279

A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.

Zhong-Wei Chen1, Huan-Ming Xiao2, Xinjian Ye3, Kun Liu3, Rafael S Rios4, Kenneth I Zheng4, Yi Jin5, Giovanni Targher6, Christopher D Byrne7, Junping Shi8, Zhihan Yan3, Xiao-Ling Chi2, Ming-Hua Zheng4,9,10.   

Abstract

Background: Currently, there are no effective methods for assessing hepatic inflammation without resorting to histological examination of liver tissue obtained by biopsy. T2-weighted images (T2WI) are routinely obtained from liver magnetic resonance imaging (MRI) scan sequences. We aimed to establish a radiomics signature based on T2WI (T2-RS) for assessment of hepatic inflammation in people with nonalcoholic fatty liver disease (NAFLD).
Methods: A total of 203 individuals with biopsy-confirmed NAFLD from two independent Chinese cohorts with liver MRI examination were enrolled in this study. The hepatic inflammatory activity score (IAS) was calculated by the unweighted sum of the histologic scores for lobular inflammation and ballooning. One thousand and thirty-two radiomics features were extracted from the localized region of interest (ROI) in the right liver lobe of T2WI and, subsequently, selected by minimum redundancy maximum relevance and least absolute shrinkage and selection operator (LASSO) methods. The T2-RS was calculated by adding the selected features weighted by their coefficients.
Results: Eighteen radiomics features from Laplacian of Gaussian, wavelet, and original images were selected for establishing T2-RS. The T2-RS value differed significantly between groups with increasing grades of hepatic inflammation (P<0.01). The T2-RS yielded an area under the receiver operating characteristic (ROC) curve (AUROC) of 0.80 [95% confidence interval (CI): 0.71-0.89] for predicting hepatic inflammation in the training cohort with excellent calibration. The AUROCs of T2-RS in the internal cohort and external validation cohorts were 0.77 (0.61-0.93) and 0.75 (0.63-0.84), respectively. Conclusions: The T2-RS derived from radiomics analysis of T2WI shows promising utility for predicting hepatic inflammation in individuals with NAFLD. 2022 Hepatobiliary Surgery and Nutrition. All rights reserved.

Entities:  

Keywords:  Nonalcoholic fatty liver disease (NAFLD); inflammation activity; magnetic resonance imaging (MRI); radiomics

Year:  2022        PMID: 35464279      PMCID: PMC9023815          DOI: 10.21037/hbsn-21-23

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  48 in total

1.  Using texture analyses of contrast enhanced CT to assess hepatic fibrosis.

Authors:  Naznin Daginawala; Baojun Li; Karen Buch; HeiShun Yu; Brian Tischler; Muhammad Mustafa Qureshi; Jorge A Soto; Stephan Anderson
Journal:  Eur J Radiol       Date:  2015-12-17       Impact factor: 3.528

Review 2.  MR elastography of liver: current status and future perspectives.

Authors:  Ilkay S Idilman; Jiahui Li; Meng Yin; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2020-07-23

Review 3.  A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

Authors:  Mohammed Eslam; Philip N Newsome; Shiv K Sarin; Quentin M Anstee; Giovanni Targher; Manuel Romero-Gomez; Shira Zelber-Sagi; Vincent Wai-Sun Wong; Jean-François Dufour; Jörn M Schattenberg; Takumi Kawaguchi; Marco Arrese; Luca Valenti; Gamal Shiha; Claudio Tiribelli; Hannele Yki-Järvinen; Jian-Gao Fan; Henning Grønbæk; Yusuf Yilmaz; Helena Cortez-Pinto; Claudia P Oliveira; Pierre Bedossa; Leon A Adams; Ming-Hua Zheng; Yasser Fouad; Wah-Kheong Chan; Nahum Mendez-Sanchez; Sang Hoon Ahn; Laurent Castera; Elisabetta Bugianesi; Vlad Ratziu; Jacob George
Journal:  J Hepatol       Date:  2020-04-08       Impact factor: 25.083

4.  Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology.

Authors:  Khoschy Schawkat; Alexander Ciritsis; Caecilia S Reiner; Sophie von Ulmenstein; Hanna Honcharova-Biletska; Christoph Jüngst; Achim Weber; Christoph Gubler; Joachim Mertens
Journal:  Eur Radiol       Date:  2020-04-08       Impact factor: 5.315

Review 5.  Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease.

Authors:  Luca Miele; Maria A Zocco; Fabrizio Pizzolante; Nicoletta De Matthaeis; Maria E Ainora; Antonio Liguori; Antonio Gasbarrini; Antonio Grieco; Gianludovico Rapaccini
Journal:  Metabolism       Date:  2020-09-09       Impact factor: 8.694

6.  T2 relaxation time is related to liver fibrosis severity.

Authors:  Alexander R Guimaraes; Luiz Siqueira; Ritika Uppal; Jamu Alford; Bryan C Fuchs; Suguru Yamada; Kenneth Tanabe; Raymond T Chung; Gregory Lauwers; Michael L Chew; Giles W Boland; Duhyant V Sahani; Mark Vangel; Peter F Hahn; Peter Caravan
Journal:  Quant Imaging Med Surg       Date:  2016-04

7.  Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

Authors:  Siddharth Verma; Donald Jensen; John Hart; Smruti R Mohanty
Journal:  Liver Int       Date:  2013-06-13       Impact factor: 5.828

8.  Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Alessandro Furlan; Mitchell E Tublin; Lan Yu; Kapil B Chopra; Anita Lippello; Jaideep Behari
Journal:  AJR Am J Roentgenol       Date:  2019-11-12       Impact factor: 3.959

9.  From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.

Authors:  Kenneth I Zheng; Jian-Gao Fan; Jun-Ping Shi; Vincent Wai-Sun Wong; Mohammed Eslam; Jacob George; Ming-Hua Zheng
Journal:  Chin Med J (Engl)       Date:  2020-10-05       Impact factor: 2.628

10.  Non-invasive fibrosis assessment in non-alcoholic fatty liver disease.

Authors:  Rafael S Rios; Kenneth I Zheng; Giovanni Targher; Christopher D Byrne; Ming-Hua Zheng
Journal:  Chin Med J (Engl)       Date:  2020-11-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.